2,170 reports of this reaction
3.3% of all GLIMEPIRIDE reports
#3 most reported adverse reaction
DIARRHOEA is the #3 most commonly reported adverse reaction for GLIMEPIRIDE, manufactured by Lifsa Drugs LLC. There are 2,170 FDA adverse event reports linking GLIMEPIRIDE to DIARRHOEA. This represents approximately 3.3% of all 66,685 adverse event reports for this drug.
Patients taking GLIMEPIRIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among GLIMEPIRIDE users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for GLIMEPIRIDE:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 2,170 FDA reports for GLIMEPIRIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.3% of all adverse event reports for GLIMEPIRIDE, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking GLIMEPIRIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.